- Report
- March 2022
- 155 Pages
Global
From €3947EUR$4,450USD£3,427GBP
- Report
- July 2024
- 155 Pages
Global
From €3204EUR$3,613USD£2,782GBP
€3770EUR$4,250USD£3,273GBP
- Report
- August 2023
- 180 Pages
Global
From €3326EUR$3,750USD£2,888GBP
- Training
- 60 Minutes
Global
The Assay Development market within the context of Diagnostics is a rapidly growing sector, with a focus on the development of tests and assays for the detection of various diseases and conditions. Assay development involves the use of a variety of technologies, such as immunoassays, molecular assays, and cell-based assays, to detect and measure the presence of a particular analyte in a sample. Assay development is a critical component of the diagnostic process, as it enables the accurate and reliable detection of a wide range of diseases and conditions.
Assay development is a complex process, requiring the integration of multiple technologies and processes. It involves the selection of appropriate reagents, the optimization of assay conditions, and the validation of the assay. Assay development is also a highly regulated process, with stringent requirements for accuracy, reliability, and reproducibility.
Companies in the Assay Development market include Abbott Laboratories, Becton Dickinson, Bio-Rad Laboratories, Cepheid, DiaSorin, GenMark Diagnostics, Hologic, Luminex, Qiagen, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more